Karl-Olof Borg
Direktor/Vorstandsmitglied bei BioCrine AB
Profil
Karl-Olof Borg is currently a Director at BioCrine AB.
He was previously a Chairman at BioInvent International AB, and a Director at Eurocine Vaccines AB, Pharmexa A, Alligator Bioscience AB, 7TM A, and Galenica AB.
Borg holds a doctorate degree from the University of Uppsala.
Aktive Positionen von Karl-Olof Borg
| Unternehmen | Position | Beginn |
|---|---|---|
| BioCrine AB | Direktor/Vorstandsmitglied | 12.05.2010 |
Ehemalige bekannte Positionen von Karl-Olof Borg
| Unternehmen | Position | Ende |
|---|---|---|
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Vorsitzender | 16.06.2009 |
7TM A/S
 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Direktor/Vorstandsmitglied | - |
Galenica AB
 Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden. | Direktor/Vorstandsmitglied | - |
| BIOINVENT INTERNATIONAL AB | Vorsitzender | - |
| EUROCINE VACCINES AB | Direktor/Vorstandsmitglied | - |
Ausbildung von Karl-Olof Borg
| University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| EUROCINE VACCINES AB | Health Technology |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
Galenica AB
Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden. | Health Technology |
| BioCrine AB | |
7TM A/S
7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Health Technology |
